Letters

Careless talk may cost lives in attributing adverse events to ADP receptor antagonists

BMJ 2002; 324 doi: http://dx.doi.org/10.1136/bmj.324.7344.1039 (Published 27 April 2002) Cite this as: BMJ 2002;324:1039
  1. Michael J Green ([email protected]), specialist registrar rheumatology,
  2. Martin Iveson, consultant rheumatologist,
  3. Robert Crook, consultant cardiologist and general physician,
  4. Nichola Burrows, senior house officer,
  5. Andrew KS Gough, consultant rheumatologist
  1. York District Hospital, Wigginton Lane, York YO31 8HE
  2. Harrogate District Hospital, Harrogate HG2 7SX

    EDITOR—Dakik et al in their article suggest an association between the prescription of an ADP receptor antagonist (ticlodipine) with the onset of acute arthritis.1 We would like to express a note of caution. This article follows a previous one discussing another ADP receptor antagonist (clopidogrel) and the development of acute arthritis.2 These drugs are increasingly used in combination with aspirin for the prevention of thrombosis after coronary artery stenting and have been shown to be safe and efficacious. 3 4 It is …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe